Advertisement

Depression during perimenopause: the role of the obstetrician-gynecologist

  • Greta B. Raglan
  • Jay Schulkin
  • Elizabeth MicksEmail author
Review Article

Abstract

Depression in women is more common during perimenopause (the transition to menopause) than at other times in the life cycle. Symptoms of depression may be different in perimenopausal women compared to younger or older women, and are often dismissed as part of normal menopause. This is an expert narrative review. There are several evidence-based screening modalities which can be integrated into routine women’s health visits, and can facilitate distinguishing between depression and normal perimenopausal symptoms. There is emerging evidence regarding the effect of hormonal changes on the development of perimenopausal depression and its optimal treatment, though critical research gaps remain. Obstetrician-gynecologists and other primary care providers play a vital role in the detection and management of depression in women. Providers caring for women during perimenopause have a unique opportunity to diagnose depression in their patients and identify appropriate treatment options.

Keywords

Perimenopause Depression Menopause Mental health Screening 

Notes

Author contributions

G Raglan: manuscript writing/editing

J Schulkin: protocol/project development

E Micks: manuscript writing/editing

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflicts of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

References

  1. Accortt EE, Wong MS (2017) It is time for routine screening for perinatal mood and anxiety disorders in obstetrics and gynecology settings? Obstet Gynecol Surv 72:553–568.  https://doi.org/10.1097/OGX.0000000000000477 CrossRefPubMedGoogle Scholar
  2. Al-Akoum M, Maunsell E, Verreault R, Provencher L, Otis H, Dodin S (2009) Effects of Hypericum perforatum (St. John’s wort) on hot flashes and quality of life in perimenopausal women: a randomized pilot trial. Menopause 16:307–314.  https://doi.org/10.1097/gme.0b013e31818572a0 CrossRefPubMedGoogle Scholar
  3. American College of O, Gynecologists Committee on Gynecologic P (2011) ACOG Committee Opinion No. 483: primary and preventive care: periodic assessments. Obstet Gynecol 117:1008–1015.  https://doi.org/10.1097/AOG.0b013e318219226e CrossRefGoogle Scholar
  4. Archer DF, Dupont CM, Constantine GD, Pickar JH, Olivier S, Study I (2009) Desvenlafaxine for the treatment of vasomotor symptoms associated with menopause: a double-blind, randomized, placebo-controlled trial of efficacy and safety. Am J Obstet Gynecol 200:238 e231–238 e210.  https://doi.org/10.1016/j.ajog.2008.10.057 CrossRefGoogle Scholar
  5. Banger M (2002) Affective syndrome during perimenopause. Maturitas 41(Suppl 1):S13–S18CrossRefGoogle Scholar
  6. Becker D, Lomranz J, Pines A, Shmotkin D, Nitza E, BennAmitay G, Mester R (2001) Psychological distress around menopause. Psychosomatics 42:252–257.  https://doi.org/10.1176/appi.psy.42.3.252 CrossRefPubMedGoogle Scholar
  7. Bennett IM, Palmer S, Marcus S, Nicholson JM, Hantsoo L, Bellamy S, Rinaldi J, Coyne JC (2009) “One end has nothing to do with the other:” patient attitudes regarding help seeking intention for depression in gynecologic and obstetric settings. Arch Womens Ment Health 12:301–308.  https://doi.org/10.1007/s00737-009-0103-4 CrossRefPubMedGoogle Scholar
  8. Berent-Spillson A, Persad CC, Love T, Sowers M, Randolph JF, Zubieta JK, Smith YR (2012) Hormonal environment affects cognition independent of age during the menopause transition. J Clin Endocrinol Metab 97:E1686–E1694.  https://doi.org/10.1210/jc.2012-1365 CrossRefPubMedPubMedCentralGoogle Scholar
  9. Bhat A, Reed SD, Unutzer J (2017) The obstetrician-gynecologist’s role in detecting, preventing, and treating depression. Obstet Gynecol 129:157–163.  https://doi.org/10.1097/AOG.0000000000001809 CrossRefPubMedPubMedCentralGoogle Scholar
  10. Birndorf CA, Madden A, Portera L, Leon AC (2001) Psychiatric symptoms, functional impairment, and receptivity toward mental health treatment among obstetrical patients. Int J Psychiatry Med 31:355–365.  https://doi.org/10.2190/5VPD-WGL1-MTWN-6JA6 CrossRefPubMedGoogle Scholar
  11. Borkoles E, Reynolds N, Thompson DR, Ski CF, Stojanovska L, Polman RC (2015) The role of depressive symptomatology in peri- and post-menopause. Maturitas 81:306–310.  https://doi.org/10.1016/j.maturitas.2015.03.007 CrossRefPubMedGoogle Scholar
  12. Borrow AP, Cameron NM (2014) Estrogenic mediation of serotonergic and neurotrophic systems: implications for female mood disorders. Prog Neuro-Psychopharmacol Biol Psychiatry 54:13–25.  https://doi.org/10.1016/j.pnpbp.2014.05.009 CrossRefGoogle Scholar
  13. Briese V, Stammwitz U, Friede M, Henneicke-von Zepelin HH (2007) Black cohosh with or without St. John’s wort for symptom-specific climacteric treatment—results of a large-scale, controlled, observational study. Maturitas 57:405–414.  https://doi.org/10.1016/j.maturitas.2007.04.008 CrossRefPubMedGoogle Scholar
  14. Bromberger JT, Assmann SF, Avis NE, Schocken M, Kravitz HM, Cordal A (2003) Persistent mood symptoms in a multiethnic community cohort of pre- and perimenopausal women. Am J Epidemiol 158:347–356CrossRefGoogle Scholar
  15. Bromberger JT, Schott LL, Kravitz HM, Sowers MF, Avis NE, Gold EB, Randolph JF, Matthews KA (2010) Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition: results from the Study of Women’s Health Across the Nation (SWAN). Arch Gen Psychiatry 67:598–607.  https://doi.org/10.1001/archgenpsychiatry.2010.55 CrossRefPubMedPubMedCentralGoogle Scholar
  16. Bromberger JT, Kravitz HM, Chang YF, Cyranowski JM, Brown C, Matthews KA (2011) Major depression during and after the menopausal transition: Study of Women’s Health Across the Nation (SWAN). Psychol Med 41:1879–1888.  https://doi.org/10.1017/S003329171100016X CrossRefPubMedPubMedCentralGoogle Scholar
  17. Bromberger JT, Schott L, Kravitz HM, Joffe H (2015) Risk factors for major depression during midlife among a community sample of women with and without prior major depression: are they the same or different? Psychol Med 45:1653–1664.  https://doi.org/10.1017/S0033291714002773 CrossRefPubMedGoogle Scholar
  18. Buist DS et al (2004) Hormone therapy prescribing patterns in the United States. Obstet Gynecol 104:1042–1050.  https://doi.org/10.1097/01.AOG.0000143826.38439.af CrossRefPubMedGoogle Scholar
  19. Cassidy JM, Boyle VA, Lawrence HC (2003) Behavioral health care integration in obstetrics and gynecology. MedGenMed 5:41PubMedGoogle Scholar
  20. Cepoiu M, McCusker J, Cole MG, Sewitch M, Belzile E, Ciampi A (2008) Recognition of depression by non-psychiatric physicians—a systematic literature review and meta-analysis. J Gen Intern Med 23:25–36.  https://doi.org/10.1007/s11606-007-0428-5 CrossRefPubMedGoogle Scholar
  21. Citarella A, Andersen M, Sundstrom A, Bardage C, Hultman CM, Kieler H (2013) Initiating therapy with antidepressants after discontinuation of hormone therapy. Menopause 20:146–151.  https://doi.org/10.1097/gme.0b013e3182611590 CrossRefPubMedGoogle Scholar
  22. Clayton AH, Ninan PT (2010) Depression or menopause? Presentation and management of major depressive disorder in perimenopausal and postmenopausal women. Prim Care Companion J Clin Psychiatry 12:PCC 08r00747.  https://doi.org/10.4088/PCC.08r00747blu CrossRefPubMedPubMedCentralGoogle Scholar
  23. Cohen D, Coco A (2014) Do physicians address other medical problems during preventive gynecologic visits? J Am Board Fam Med 27:13–18.  https://doi.org/10.3122/jabfm.2014.01.130045 CrossRefPubMedGoogle Scholar
  24. Cohen LS, Soares CN, Vitonis AF, Otto MW, Harlow BL (2006) Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Arch Gen Psychiatry 63:385–390.  https://doi.org/10.1001/archpsyc.63.4.385 CrossRefPubMedGoogle Scholar
  25. de Kruif M, Spijker AT, Molendijk ML (2016) Depression during the perimenopause: a meta-analysis. J Affect Disord 206:174–180.  https://doi.org/10.1016/j.jad.2016.07.040 CrossRefPubMedGoogle Scholar
  26. Deligiannidis KM, Freeman MP (2010) Complementary and alternative medicine for the treatment of depressive disorders in women. Psychiatr Clin North Am 33:441–463.  https://doi.org/10.1016/j.psc.2010.01.002 CrossRefPubMedGoogle Scholar
  27. Dennerstein L, Soares CN (2008) The unique challenges of managing depression in mid-life women. World Psychiatry 7:137–142CrossRefGoogle Scholar
  28. Dennerstein L, Lehert P, Guthrie J (2002) The effects of the menopausal transition and biopsychosocial factors on well-being. Arch Womens Ment Health 5:15–22.  https://doi.org/10.1007/s007370200018 CrossRefPubMedGoogle Scholar
  29. Ehrenthal DB, Nunez AE, O'Neill E, Robertson-James C, Addo SF, Stewart A (2011) The role of the obstetrician/gynecologist in the prevention of cardiovascular disease in women. Womens Health Issues 21:338–344.  https://doi.org/10.1016/j.whi.2011.04.012 CrossRefPubMedGoogle Scholar
  30. Elavsky S, McAuley E (2007) Physical activity and mental health outcomes during menopause: a randomized controlled trial. Ann Behav Med 33:132–142.  https://doi.org/10.1080/08836610701307983 CrossRefPubMedGoogle Scholar
  31. Epstein RM, Duberstein PR, Feldman MD, Rochlen AB, Bell RA, Kravitz RL, Cipri C, Becker JD, Bamonti PM, Paterniti DA (2010) “I didn’t know what was wrong:” how people with undiagnosed depression recognize, name and explain their distress. J Gen Intern Med 25:954–961.  https://doi.org/10.1007/s11606-010-1367-0 CrossRefPubMedPubMedCentralGoogle Scholar
  32. Fink KS, Baldwin LM, Lawson HW, Chan L, Rosenblatt RA, Hart LG (2001) The role of gynecologists in providing primary care to elderly women. J Fam Pract 50:153–158PubMedGoogle Scholar
  33. Fischer B, Gleason C, Asthana S (2014) Effects of hormone therapy on cognition and mood. Fertil Steril 101:898–904.  https://doi.org/10.1016/j.fertnstert.2014.02.025 CrossRefPubMedPubMedCentralGoogle Scholar
  34. Flores-Ramos M, Heinze G, Silvestri-Tomassoni R (2010) Association between depressive symptoms and reproductive variables in a group of perimenopausal women attending a menopause clinic in Mexico City. Arch Womens Ment Health 13:99–105.  https://doi.org/10.1007/s00737-009-0107-0 CrossRefPubMedGoogle Scholar
  35. Freeman EW, Sammel MD, Liu L, Gracia CR, Nelson DB, Hollander L (2004) Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry 61:62–70.  https://doi.org/10.1001/archpsyc.61.1.62 CrossRefPubMedGoogle Scholar
  36. Freeman EW, Sammel MD, Lin H, Nelson DB (2006a) Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry 63:375–382.  https://doi.org/10.1001/archpsyc.63.4.375 CrossRefPubMedGoogle Scholar
  37. Freeman MP, Hill R, Brumbach BH (2006b) Escitalopram for perimenopausal depression: an open-label pilot study. J Women's Health (Larchmt) 15:857–861.  https://doi.org/10.1089/jwh.2006.15.857 CrossRefGoogle Scholar
  38. Freeman MP, Hirschberg AM, Wang B, Petrillo LF, Connors S, Regan S, Joffe H, Cohen LS (2013) Duloxetine for major depressive disorder and daytime and nighttime hot flashes associated with the menopausal transition. Maturitas 75:170–174.  https://doi.org/10.1016/j.maturitas.2013.03.007 CrossRefPubMedGoogle Scholar
  39. Frey BNSC (2009) Managing depression and anxiety during the menopausal transition and beyond: the window of vulnerability. In: Soares CNWM (ed) The menopausal transition: interface between gynecology and psychiatry. Karger, New York, pp 102–114CrossRefGoogle Scholar
  40. Fuller E, Anderson B, Leddy M, Schulkin J (2013) Obstetrician-gynecologists’ knowledge, attitudes and practices regarding major depressive disorder. J Psychosom Obstet Gynaecol 34:34–38.  https://doi.org/10.3109/0167482X.2012.752811 CrossRefPubMedGoogle Scholar
  41. Gallicchio L, Schilling C, Miller SR, Zacur H, Flaws JA (2007) Correlates of depressive symptoms among women undergoing the menopausal transition. J Psychosom Res 63:263–268.  https://doi.org/10.1016/j.jpsychores.2007.02.003 CrossRefPubMedGoogle Scholar
  42. Galvan T, Camuso J, Sullivan K, Kim S, White D, Redline S, Joffe H (2017) Association of estradiol with sleep apnea in depressed perimenopausal and postmenopausal women: a preliminary study. Menopause 24:112–117.  https://doi.org/10.1097/GME.0000000000000737 CrossRefPubMedPubMedCentralGoogle Scholar
  43. Gibbs Z, Lee S, Kulkarni J (2012) What factors determine whether a woman becomes depressed during the perimenopause? Arch Womens Ment Health 15:323–332.  https://doi.org/10.1007/s00737-012-0304-0 CrossRefPubMedGoogle Scholar
  44. Gibbs Z, Lee S, Kulkarni J (2013) Factors associated with depression during the perimenopausal transition. Womens Health Issues 23:e301–e307.  https://doi.org/10.1016/j.whi.2013.07.001 CrossRefPubMedGoogle Scholar
  45. Gibbs Z, Lee S, Kulkarni J (2015) The unique symptom profile of perimenopausal depression. Clin Psychol 19:76–84CrossRefGoogle Scholar
  46. Gleason CE et al (2015) Effects of hormone therapy on cognition and mood in recently postmenopausal women: findings from the randomized, controlled KEEPS-cognitive and affective study. PLoS Med 12:e1001833; discussion e1001833.  https://doi.org/10.1371/journal.pmed.1001833 CrossRefPubMedPubMedCentralGoogle Scholar
  47. Gordon JL, Girdler SS, Meltzer-Brody SE, Stika CS, Thurston RC, Clark CT, Prairie BA, Moses-Kolko E, Joffe H, Wisner KL (2015) Ovarian hormone fluctuation, neurosteroids, and HPA axis dysregulation in perimenopausal depression: a novel heuristic model. Am J Psychiatry 172:227–236.  https://doi.org/10.1176/appi.ajp.2014.14070918 CrossRefPubMedPubMedCentralGoogle Scholar
  48. Gordon JL, Rubinow DR, Eisenlohr-Moul TA, Leserman J, Girdler SS (2016) Estradiol variability, stressful life events, and the emergence of depressive symptomatology during the menopausal transition. Menopause 23:257–266.  https://doi.org/10.1097/GME.0000000000000528 CrossRefPubMedPubMedCentralGoogle Scholar
  49. Gordon JL, Rubinow DR, Eisenlohr-Moul TA, Xia K, Schmidt PJ, Girdler SS (2018) Efficacy of transdermal estradiol and micronized progesterone in the prevention of depressive symptoms in the menopause transition: a randomized clinical trial. JAMA Psychiatry 75:149–157.  https://doi.org/10.1001/jamapsychiatry.2017.3998 CrossRefPubMedPubMedCentralGoogle Scholar
  50. Graziottin A, Serafini A (2009) Depression and the menopause: why antidepressants are not enough? Menopause Int 15:76–81.  https://doi.org/10.1258/mi.2009.009021 CrossRefPubMedGoogle Scholar
  51. Green SM, Key BL, McCabe RE (2015) Cognitive-behavioral, behavioral, and mindfulness-based therapies for menopausal depression: a review. Maturitas 80:37–47.  https://doi.org/10.1016/j.maturitas.2014.10.004 CrossRefPubMedGoogle Scholar
  52. Grigoriadis S, Kennedy SH, Bagby RM (2003) A comparison of antidepressant response in younger and older women. J Clin Psychopharmacol 23:405–407.  https://doi.org/10.1097/01.jcp.0000085415.08426.c6 CrossRefPubMedGoogle Scholar
  53. Gyllstrom ME, Schreiner PJ, Harlow BL (2007) Perimenopause and depression: strength of association, causal mechanisms and treatment recommendations. Best Pract Res Clin Obstet Gynaecol 21:275–292.  https://doi.org/10.1016/j.bpobgyn.2006.11.002 CrossRefPubMedGoogle Scholar
  54. Hale RW (1995) The obstetrician and gynecologist: primary care physician or specialist? Am J Obstet Gynecol 172:1181–1183CrossRefGoogle Scholar
  55. Harlow SD, Gass M, Hall JE, Lobo R, Maki P, Rebar RW, Sherman S, Sluss PM, de Villiers TJ (2012) Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. Fertil Steril 97:843–851.  https://doi.org/10.1016/j.fertnstert.2012.01.128 CrossRefPubMedPubMedCentralGoogle Scholar
  56. Harsh V, Meltzer-Brody S, Rubinow DR, Schmidt PJ (2009) Reproductive aging, sex steroids, and mood disorders. Harv Rev Psychiatry 17:87–102.  https://doi.org/10.1080/10673220902891877 CrossRefPubMedPubMedCentralGoogle Scholar
  57. Henderson JT, Weisman CS, Grason H (2002) Are two doctors better than one? Women’s physician use and appropriate care. Womens Health Issues 12:138–149CrossRefGoogle Scholar
  58. Hill LD, Gray JJ, Carter MM, Schulkin J (2005) Obstetrician-gynecologists’ decision making about the diagnosis of major depressive disorder and premenstrual dysphoric disorder. J Psychosom Obstet Gynaecol 26:41–51CrossRefGoogle Scholar
  59. Hollon SD, DeRubeis RJ, Fawcett J, Amsterdam JD, Shelton RC, Zajecka J, Young PR, Gallop R (2014) Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial. JAMA Psychiatry 71:1157–1164.  https://doi.org/10.1001/jamapsychiatry.2014.1054 CrossRefPubMedPubMedCentralGoogle Scholar
  60. Joffe H, Soares CN, Petrillo LF, Viguera AC, Somley BL, Koch JK, Cohen LS (2007) Treatment of depression and menopause-related symptoms with the serotonin-norepinephrine reuptake inhibitor duloxetine. J Clin Psychiatry 68:943–950CrossRefGoogle Scholar
  61. Joffe H, Crawford SL, Freeman MP, White DP, Bianchi MT, Kim S, Economou N, Camuso J, Hall JE, Cohen LS (2016) Independent contributions of nocturnal hot flashes and sleep disturbance to depression in estrogen-deprived women. J Clin Endocrinol Metab 101:3847–3855.  https://doi.org/10.1210/jc.2016-2348 CrossRefPubMedPubMedCentralGoogle Scholar
  62. Judd FK, Hickey M, Bryant C (2012) Depression and midlife: are we overpathologising the menopause? J Affect Disord 136:199–211.  https://doi.org/10.1016/j.jad.2010.12.010 CrossRefPubMedGoogle Scholar
  63. Kai Y, Nagamatsu T, Kitabatake Y, Sensui H (2016) Effects of stretching on menopausal and depressive symptoms in middle-aged women: a randomized controlled trial. Menopause 23:827–832.  https://doi.org/10.1097/GME.0000000000000651 CrossRefPubMedPubMedCentralGoogle Scholar
  64. Karaoulanis SE, Daponte A, Rizouli KA, Rizoulis AA, Lialios GA, Theodoridou CT, Christakopoulos C, Angelopoulos NV (2012) The role of cytokines and hot flashes in perimenopausal depression. Ann General Psychiatry 11:9.  https://doi.org/10.1186/1744-859X-11-9 CrossRefGoogle Scholar
  65. Keller MB, McCullough JP, Klein DN, Arnow B, Dunner DL, Gelenberg AJ, Markowitz JC, Nemeroff CB, Russell JM, Thase ME, Trivedi MH, Blalock JA, Borian FE, Jody DN, DeBattista C, Koran LM, Schatzberg AF, Fawcett J, Hirschfeld RMA, Keitner G, Miller I, Kocsis JH, Kornstein SG, Manber R, Ninan PT, Rothbaum B, Rush AJ, Vivian D, Zajecka J (2000) A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med 342:1462–1470.  https://doi.org/10.1056/NEJM200005183422001 CrossRefPubMedGoogle Scholar
  66. Kim JJ, La Porte LM, Adams MG, Gordon TE, Kuendig JM, Silver RK (2009) Obstetric care provider engagement in a perinatal depression screening program. Arch Womens Ment Health 12:167–172.  https://doi.org/10.1007/s00737-009-0057-6 CrossRefPubMedGoogle Scholar
  67. Kornstein SG, Clayton AH, Bao W, Guico-Pabia CJ (2015) A pooled analysis of the efficacy of desvenlafaxine for the treatment of major depressive disorder in perimenopausal and postmenopausal women. J Women's Health (Larchmt) 24:281–290.  https://doi.org/10.1089/jwh.2014.4900 CrossRefGoogle Scholar
  68. LaRocco-Cockburn A, Melville J, Bell M, Katon W (2003) Depression screening attitudes and practices among obstetrician-gynecologists. Obstet Gynecol 101:892–898CrossRefGoogle Scholar
  69. Leddy M, Haaga D, Gray J, Schulkin J (2011) Postpartum mental health screening and diagnosis by obstetrician-gynecologists. J Psychosom Obstet Gynaecol 32:27–34.  https://doi.org/10.3109/0167482X.2010.547639 CrossRefPubMedGoogle Scholar
  70. Lewis BG, Halm EA, Marcus SM, Korenstein D, Federman AD (2008) Preventive services use among women seen by gynecologists, general medical physicians, or both. Obstet Gynecol 111:945–952.  https://doi.org/10.1097/AOG.0b013e318169ce3e CrossRefPubMedGoogle Scholar
  71. Llaneza P, Garcia-Portilla MP, Llaneza-Suarez D, Armott B, Perez-Lopez FR (2012) Depressive disorders and the menopause transition. Maturitas 71:120–130.  https://doi.org/10.1016/j.maturitas.2011.11.017 CrossRefPubMedGoogle Scholar
  72. Lobo RA et al (2006) Should symptomatic menopausal women be offered hormone therapy? MedGenMed 8:40PubMedPubMedCentralGoogle Scholar
  73. Macias-Cortes Edel C, Llanes-Gonzalez L, Aguilar-Faisal L, Asbun-Bojalil J (2015) Individualized homeopathic treatment and fluoxetine for moderate to severe depression in peri- and postmenopausal women (HOMDEP-MENOP study): a randomized, double-dummy, double-blind, placebo-controlled trial. PLoS One 10:e0118440.  https://doi.org/10.1371/journal.pone.0118440 CrossRefPubMedGoogle Scholar
  74. Marsh WK, Ketter TA, Crawford SL, Johnson JV, Kroll-Desrosiers AR, Rothschild AJ (2012) Progression of female reproductive stages associated with bipolar illness exacerbation. Bipolar Disord 14:515–526.  https://doi.org/10.1111/j.1399-5618.2012.01026.x CrossRefPubMedPubMedCentralGoogle Scholar
  75. Marsh WK, Bromberger JT, Crawford SL, Leung K, Kravitz HM, Randolph JF, Joffe H, Soares CN (2017) Lifelong estradiol exposure and risk of depressive symptoms during the transition to menopause and postmenopause. Menopause 24:1351–1359.  https://doi.org/10.1097/GME.0000000000000929 CrossRefPubMedPubMedCentralGoogle Scholar
  76. Matthews KA, Wing RR, Kuller LH, Meilahn EN, Kelsey SF, Costello EJ, Caggiula AW (1990) Influences of natural menopause on psychological characteristics and symptoms of middle-aged healthy women. J Consult Clin Psychol 58:345–351CrossRefGoogle Scholar
  77. McCurry SM et al (2016) Telephone-based cognitive behavioral therapy for insomnia in perimenopausal and postmenopausal women with vasomotor symptoms: a MsFLASH randomized clinical trial. JAMA Intern Med 176:913–920.  https://doi.org/10.1001/jamainternmed.2016.1795 CrossRefPubMedPubMedCentralGoogle Scholar
  78. McIntyre RS et al (2005) Hormone replacement therapy and antidepressant prescription patterns: a reciprocal relationship. CMAJ 172:57–59.  https://doi.org/10.1503/cmaj.1040517 CrossRefPubMedPubMedCentralGoogle Scholar
  79. Mishra GD, Brown WJ, Dobson AJ (2003) Physical and mental health: changes during menopause transition. Qual Life Res 12:405–412CrossRefGoogle Scholar
  80. Morgan ML, Cook IA, Rapkin AJ, Leuchter AF (2007) Neurophysiologic changes during estrogen augmentation in perimenopausal depression. Maturitas 56:54–60.  https://doi.org/10.1016/j.maturitas.2006.05.010 CrossRefPubMedGoogle Scholar
  81. Morrison MF, Freeman EW, Lin H, Sammel MD (2011) Higher DHEA-S (dehydroepiandrosterone sulfate) levels are associated with depressive symptoms during the menopausal transition: results from the PENN Ovarian Aging Study. Arch Womens Ment Health 14:375–382.  https://doi.org/10.1007/s00737-011-0231-5 CrossRefPubMedPubMedCentralGoogle Scholar
  82. Mulhall S, Andel R, Anstey KJ (2018) Variation in symptoms of depression and anxiety in midlife women by menopausal status. Maturitas 108:7–12.  https://doi.org/10.1016/j.maturitas.2017.11.005 CrossRefPubMedGoogle Scholar
  83. Natari RB, Clavarino AM, McGuire TM, Dingle KD, Hollingworth SA (2018) The bidirectional relationship between vasomotor symptoms and depression across the menopausal transition: a systematic review of longitudinal studies. Menopause 25:109–120.  https://doi.org/10.1097/GME.0000000000000949 CrossRefPubMedGoogle Scholar
  84. Parry BL (2008) Perimenopausal depression. Am J Psychiatry 165:23–27.  https://doi.org/10.1176/appi.ajp.2007.07071152 CrossRefPubMedGoogle Scholar
  85. Parry BL (2010) Optimal management of perimenopausal depression. Int J Women's Health 2:143–151CrossRefGoogle Scholar
  86. Qu F, Cai X, Gu Y, Zhou J, Zhang R, Burrows E, Huang H (2009) Chinese medicinal herbs in relieving perimenopausal depression: a randomized, controlled trial. J Altern Complement Med 15:93–100.  https://doi.org/10.1089/acm.2008.0267 CrossRefPubMedGoogle Scholar
  87. Raglan G, Lawrence H III, Schulkin J (2014) Obstetrician/gynecologist care considerations: practice changes in disease management with an aging patient population. Womens Health (Lond) 10:155–160.  https://doi.org/10.2217/whe.14.5 CrossRefGoogle Scholar
  88. Rauma PH, Honkanen RJ, Williams LJ, Tuppurainen MT, Kroger HP, Koivumaa-Honkanen H (2016) Effects of antidepressants on postmenopausal bone loss—a 5-year longitudinal study from the OSTPRE cohort. Bone 89:25–31.  https://doi.org/10.1016/j.bone.2016.05.003 CrossRefPubMedGoogle Scholar
  89. Riecher-Rossler A, de Geyter C (2007) The forthcoming role of treatment with oestrogens in mental health. Swiss Med Wkly 137:565–572PubMedGoogle Scholar
  90. Rossouw JE et al (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 288:321–333CrossRefGoogle Scholar
  91. Rozycka A et al (2016) The MAOA, COMT, MTHFR and ESR1 gene polymorphisms are associated with the risk of depression in menopausal women. Maturitas 84:42–54.  https://doi.org/10.1016/j.maturitas.2015.10.011 CrossRefPubMedGoogle Scholar
  92. Rubinow DRSP (2003) Menstrual cycle-related and perimenopause-related affective disorders. In: Wolkowitz OMRA (ed) Psychoneuroendocrinology: the scientific basis of clinical practice. American Psychiatric Publishing Inc, Arlington, pp 245–279Google Scholar
  93. Rubinow DR, Johnson SL, Schmidt PJ, Girdler S, Gaynes B (2015) Efficacy of estradiol in perimenopausal depression: so much promise and so few answers. Depress Anxiety 32:539–549.  https://doi.org/10.1002/da.22391 CrossRefPubMedPubMedCentralGoogle Scholar
  94. Ryan J, Burger HG, Szoeke C, Lehert P, Ancelin ML, Henderson VW, Dennerstein L (2009) A prospective study of the association between endogenous hormones and depressive symptoms in postmenopausal women. Menopause 16:509–517.  https://doi.org/10.1097/gme.0b013e31818d635f CrossRefPubMedPubMedCentralGoogle Scholar
  95. Sajatovic M, Rosenthal MB, Plax MS, Meyer ML, Bingham CR (2003) Mental illness and menopause: a patient and family perspective. J Gend Specif Med 6:31–34PubMedGoogle Scholar
  96. Schmidt PJ (2005) Mood, depression, and reproductive hormones in the menopausal transition. Am J Med 118(Suppl 12B):54–58.  https://doi.org/10.1016/j.amjmed.2005.09.033 CrossRefPubMedGoogle Scholar
  97. Schmidt PJ, Rubinow DR (2009) Sex hormones and mood in the perimenopause. Ann N Y Acad Sci 1179:70–85.  https://doi.org/10.1111/j.1749-6632.2009.04982.x CrossRefPubMedPubMedCentralGoogle Scholar
  98. Schmidt LA, Greenberg BD, Holzman GB, Schulkin J (1997) Treatment of depression by obstetrician-gynecologists: a survey study. Obstet Gynecol 90:296–300.  https://doi.org/10.1016/S0029-7844(97)00255-X CrossRefPubMedGoogle Scholar
  99. Schmidt PJ, Nieman L, Danaceau MA, Tobin MB, Roca CA, Murphy JH, Rubinow DR (2000) Estrogen replacement in perimenopause-related depression: a preliminary report. Am J Obstet Gynecol 183:414–420.  https://doi.org/10.1067/mob.2000.106004 CrossRefPubMedGoogle Scholar
  100. Schmidt PJ, Murphy JH, Haq N, Danaceau MA, St Clair L (2002) Basal plasma hormone levels in depressed perimenopausal women. Psychoneuroendocrinology 27:907–920CrossRefGoogle Scholar
  101. Schmidt PJ, Haq N, Rubinow DR (2004) A longitudinal evaluation of the relationship between reproductive status and mood in perimenopausal women. Am J Psychiatry 161:2238–2244.  https://doi.org/10.1176/appi.ajp.161.12.2238 CrossRefPubMedGoogle Scholar
  102. Schmidt PJ, Daly RC, Bloch M, Smith MJ, Danaceau MA, Simpson St. Clair L, Murphy JH, Haq N, Rubinow DR (2005) Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression. Arch Gen Psychiatry 62:154–162.  https://doi.org/10.1001/archpsyc.62.2.154 CrossRefPubMedGoogle Scholar
  103. Schmidt PJ, Ben Dor R, Martinez PE, Guerrieri GM, Harsh VL, Thompson K, Koziol DE, Nieman LK, Rubinow DR (2015) Effects of estradiol withdrawal on mood in women with past perimenopausal depression: a randomized clinical trial. JAMA Psychiatry 72:714–726.  https://doi.org/10.1001/jamapsychiatry.2015.0111 CrossRefPubMedGoogle Scholar
  104. Schneider HP (2002) The quality of life in the post-menopausal woman. Best Pract Res Clin Obstet Gynaecol 16:395–409CrossRefGoogle Scholar
  105. Scholle SH, Kelleher K (2003) Assessing primary care performance in an obstetrics/gynecology clinic. Women Health 37:15–30.  https://doi.org/10.1300/J013v37n01_02 CrossRefPubMedGoogle Scholar
  106. Seritan AL, Iosif AM, Park JH, DeatherageHand D, Sweet RL, Gold EB (2010) Self-reported anxiety, depressive, and vasomotor symptoms: a study of perimenopausal women presenting to a specialized midlife assessment center. Menopause 17:410–415.  https://doi.org/10.1097/gme.0b013e3181bf5a62 CrossRefPubMedGoogle Scholar
  107. Sheu YH, Lanteigne A, Sturmer T, Pate V, Azrael D, Miller M (2015) SSRI use and risk of fractures among perimenopausal women without mental disorders. Inj Prev 21:397–403.  https://doi.org/10.1136/injuryprev-2014-041483 CrossRefPubMedGoogle Scholar
  108. Smith-DiJulio K, Woods NF, Mitchell ES (2008) Well-being during the menopausal transition and early postmenopause: a within-stage analysis. Womens Health Issues 18:310–318.  https://doi.org/10.1016/j.whi.2008.03.001 CrossRefPubMedGoogle Scholar
  109. Soares CN (2014) Mood disorders in midlife women: understanding the critical window and its clinical implications. Menopause 21:198–206.  https://doi.org/10.1097/GME.0000000000000193 CrossRefPubMedGoogle Scholar
  110. Soares CN (2017) Depression and menopause: current knowledge and clinical recommendations for a critical window. Psychiatr Clin North Am 40:239–254.  https://doi.org/10.1016/j.psc.2017.01.007 CrossRefPubMedGoogle Scholar
  111. Soares CN, Arsenio H, Joffe H, Bankier B, Cassano P, Petrillo LF, Cohen LS (2006) Escitalopram versus ethinyl estradiol and norethindrone acetate for symptomatic peri- and postmenopausal women: impact on depression, vasomotor symptoms, sleep, and quality of life. Menopause 13:780–786.  https://doi.org/10.1097/01.gme.0000240633.46300.fa CrossRefPubMedGoogle Scholar
  112. Soares CN, Thase ME, Clayton A, Guico-Pabia CJ, Focht K, Jiang Q, Kornstein SG, Ninan P, Kane CP, Cohen LS (2010) Desvenlafaxine and escitalopram for the treatment of postmenopausal women with major depressive disorder. Menopause 17:700–711.  https://doi.org/10.1097/gme.0b013e3181d88962 CrossRefPubMedGoogle Scholar
  113. Steinberg EM, Rubinow DR, Bartko JJ, Fortinsky PM, Haq N, Thompson K, Schmidt PJ (2008) A cross-sectional evaluation of perimenopausal depression. J Clin Psychiatry 69:973–980CrossRefGoogle Scholar
  114. Steiner M, Dunn E, Born L (2003) Hormones and mood: from menarche to menopause and beyond. J Affect Disord 74:67–83CrossRefGoogle Scholar
  115. Stuenkel CA, Gass ML, Manson JE, Lobo RA, Pal L, Rebar RW, Hall JE (2012) A decade after the Women’s Health Initiative—the experts do agree. Menopause 19:846–847.  https://doi.org/10.1097/gme.0b013e31826226f2 CrossRefPubMedGoogle Scholar
  116. Timur S, Sahin NH (2010) The prevalence of depression symptoms and influencing factors among perimenopausal and postmenopausal women. Menopause 17:545–551.  https://doi.org/10.1097/gme.0b013e3181cf8997 CrossRefPubMedGoogle Scholar
  117. Toffol E, Heikinheimo O, Partonen T (2015) Hormone therapy and mood in perimenopausal and postmenopausal women: a narrative review. Menopause 22:564–578.  https://doi.org/10.1097/GME.0000000000000323 CrossRefPubMedGoogle Scholar
  118. Treloar AE (1981) Menstrual cyclicity and the pre-menopause. Maturitas 3:249–264CrossRefGoogle Scholar
  119. Vivian-Taylor J, Hickey M (2014) Menopause and depression: is there a link? Maturitas 79:142–146.  https://doi.org/10.1016/j.maturitas.2014.05.014 CrossRefPubMedGoogle Scholar
  120. Vousoura E, Spyropoulou AC, Koundi KL, Tzavara C, Verdeli H, Paparrigopoulos T, Augoulea A, Lambrinoudaki I, Zervas IM (2015) Vasomotor and depression symptoms may be associated with different sleep disturbance patterns in postmenopausal women. Menopause 22:1053–1057.  https://doi.org/10.1097/GME.0000000000000442 CrossRefPubMedGoogle Scholar
  121. Weisman CS, Cassard SD, Plichta SB (1995) Types of physicians used by women for regular health care: implications for services received. J Women's Health 4:407–416CrossRefGoogle Scholar
  122. Weissman MM (1979) The myth of involutional melancholia. JAMA 242:742–744CrossRefGoogle Scholar
  123. Wharton W, Gleason CE, Olson SR, Carlsson CM, Asthana S (2012) Neurobiological underpinnings of the estrogen—mood relationship. Curr Psychiatr Rev 8:247–256.  https://doi.org/10.2174/157340012800792957 CrossRefGoogle Scholar
  124. Wheaton AG, Perry GS, Chapman DP, Croft JB (2012) Sleep disordered breathing and depression among U.S. adults: National Health and Nutrition Examination Survey, 2005-2008. Sleep 35:461–467.  https://doi.org/10.5665/sleep.1724 CrossRefPubMedPubMedCentralGoogle Scholar
  125. Williams JW Jr, Rost K, Dietrich AJ, Ciotti MC, Zyzanski SJ, Cornell J (1999) Primary care physicians’ approach to depressive disorders. Effects of physician specialty and practice structure. Arch Fam Med 8:58–67CrossRefGoogle Scholar
  126. Woods NF, Smith-Dijulio K, Percival DB, Tao EY, Taylor HJ, Mitchell ES (2007) Symptoms during the menopausal transition and early postmenopause and their relation to endocrine levels over time: observations from the Seattle Midlife Women’s Health Study. J Women's Health (Larchmt) 16:667–677.  https://doi.org/10.1089/jwh.2006.0138 CrossRefGoogle Scholar
  127. Wroolie TE, Williams KE, Keller J, Zappert LN, Shelton SD, Kenna HA, Reynolds MF, Rasgon NL (2006) Mood and neuropsychological changes in women with midlife depression treated with escitalopram. J Clin Psychopharmacol 26:361–366.  https://doi.org/10.1097/01.jcp.0000227699.26375.f8 CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Austria, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of PsychiatryUniversity of MichiganAnn ArborUSA
  2. 2.Department of Obstetrics and GynecologyUniversity of Washington School of MedicineSeattleUSA

Personalised recommendations